Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Return on Equity (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Return on Equity data on record, last reported at 2.47% in Q3 2025.

  • For Q3 2025, Return on Equity rose 356.0% year-over-year to 2.47%; the TTM value through Sep 2025 reached 2.47%, up 356.0%, while the annual FY2024 figure was 1.23%, 358.0% up from the prior year.
  • Return on Equity reached 2.47% in Q3 2025 per GOSS's latest filing, down from 5.4% in the prior quarter.
  • Across five years, Return on Equity topped out at 27.37% in Q1 2023 and bottomed at 9.11% in Q3 2023.
  • Average Return on Equity over 4 years is 0.8%, with a median of 1.42% recorded in 2024.
  • The widest YoY moves for Return on Equity: up 803bps in 2024, down -3138bps in 2024.
  • A 4-year view of Return on Equity shows it stood at 6.75% in 2022, then soared by 67bps to 2.21% in 2023, then skyrocketed by 41bps to 1.31% in 2024, then soared by 288bps to 2.47% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 2.47% in Q3 2025, 5.4% in Q2 2025, and 4.26% in Q1 2025.